Lipostabil Injectable Fat Burner “Supplement” Draws FDA Warning Letter
This article was originally published in The Tan Sheet
Executive Summary
An FDA warning letter recipient who marketed injectable phosphatidylcholine as a dietary supplement over the Web is no longer selling the product directly but is referring consumers to sellers overseas
You may also be interested in...
FDA Turns Up Heat On Dietary Supplement Manufacturers As WLs Increase
FDA has issued three times as many warning letters to dietary supplement manufacturers in the first eight months of this year than in all of 2002, according to FDA Commissioner Mark McClellan, MD/PhD
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands